1

dm+d User Guide

Information Standards Delivery

Purpose of this user guide

• To highlight what dm+d is• To create awareness about dm+d as an NHS

Standard• To provide general guidance to facilitate

incorporation into healthcare systems • To point users to other more detailed

guidance documents currently available

Audience

This is a high level document aimed at those:• Who need a basic understanding of dm+d

and its intended use in the NHS• Required to adhere to the ISB 0052 dm+d

Standard• Gain a better understanding of the

relationship between dm+d and the SNOMED CT UK Drug Extension

When reviewing the document

• This document is work in progress and readers are requested to provide feedback so we can make a useful and informative document.

• In particular:– Sections that are unclear, requiring clarification– Gaps in the guidance

• any information you would consider useful and currently missing or not provided in enough detail

When reviewing the document

– Is more technical guidance in finding, downloading and handling the files required?

– Is referencing other guidance/documentation useful or should certain content (to be specified) be incorporated into this document?

– Section 4 – Using dm+d data – what other information would be useful to include in this section?

When reviewing the document

• Is further content about the SNOMED CT UK Drug Extension (for Sections 7/8) required? E.g. – Realm description subsets– Bonus files– Further information about e-prescribing

subsets and how they are used to support secondary care implementation guidance

dm+d Overview – Section 3

• What is dm+d– Background– Purpose– Links with DH Information Strategy

• Brief overview of the dm+d model• Description of more detailed documents

and where to find them

Using dm+d data – Section 4

• Electronic prescribing and administration systems (ePMA)

• Pharmacy systems• Medicines reconciliation on admission and

discharge• Transfer of medicines information

dm+d Standard – ISB 0052 – Section 5

• Information Standards Board (ISB) 0052– What is the Standard– Purpose of the Standard– Complying with the Standard– Links to more detailed documentation

dm+d coverage – Section 6

• What products are in dm+d• Future plans for increasing scope of

content (have not included yet but may be worth including a section)

• Content within dm+d that must be used to comply with the dm+d Standard

Obtaining dm+d data – Section 7

• Where to find dm+d data• What is available for download

– dm+d– SNOMED CT UK Drug Extension

• Licences required• Frequency of downloads• File structure / naming

dm+d vs. SNOMED CT UK Drug Extension - Section 8

• What is the SNOMED CT (SCT) UK Drug Extension

• Purpose of the SCT UK Drug Extension• What is the difference between the dm+d

and the SCT UK Drug Extension• Which one to use• SNOMED CT identifiers

Updates to dm+d – Section 9

• Frequency of updates• Expected weekly changes to content • Changes to Editorial Policy & Model• Helpdesk

– Requesting additions– Reporting issues

Importing dm+d data (Appendices)

• Appendices will include:– How to import dm+d xml into Microsoft Excel– (see separate attachment)– Would a similar document for importing dm+d

xml into Microsoft Access be of value?

Additional content to be worked on

Pending feedback • Further content about the SNOMED CT UK

Drug Extension (for Sections 7/8)– Realm description subsets– Bonus files– Further information about e-prescribing

subsets and how they are used to support secondary care implementation guidance